Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed.

Sibaud, V; Brun, A; Meyer, N; Oberic, L; Lamant, L; Ysebaert, L

Sibaud, V; Brun, A; Meyer, N; Oberic, L; Lamant, L; Ysebaert, L.

Afiliação

Sibaud V; Oncodermatology Department, Institut Claudius Regaud and Institut, Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Brun A; Oncodermatology Department, Institut Claudius Regaud and Institut, Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Meyer N; Oncodermatology Department, Institut Claudius Regaud and Institut, Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Oberic L; Haematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Lamant L; Pathology Department, Institut Claudius Regaud and Institut, Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Ysebaert L; Haematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.

J Eur Acad Dermatol Venereol ; 36(3): e213-e215, 2022 Mar.

Article em En | MEDLINE | ID: mdl-34657337

Assuntos

Neoplasias Hematológicas; Leucemia Linfocítica Crônica de Células B; Dermatopatias; Anticorpos Monoclonais Humanizados; Humanos; Dermatopatias/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Leucemia Linfocítica Crônica de Células B / Neoplasias Hematológicas Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google